These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 8384066)
1. Survival benefit of tamoxifen therapy in adenocarcinoma of pancreas. A case-control study. Wong A; Chan A Cancer; 1993 Apr; 71(7):2200-3. PubMed ID: 8384066 [TBL] [Abstract][Full Text] [Related]
2. Tamoxifen therapy in unresectable adenocarcinoma of the pancreas. Wong A; Chan A; Arthur K Cancer Treat Rep; 1987; 71(7-8):749-50. PubMed ID: 3038316 [TBL] [Abstract][Full Text] [Related]
3. Low dose octreotide and tamoxifen in the treatment of adenocarcinoma of the pancreas. Rosenberg L; Barkun AN; Denis MH; Pollak M Cancer; 1995 Jan; 75(1):23-8. PubMed ID: 7804972 [TBL] [Abstract][Full Text] [Related]
4. The beneficial effect of tamoxifen therapy in patients with resected adenocarcinoma of the pancreas. Horimi T; Takasaki M; Toki A; Nishimura W; Morita S Hepatogastroenterology; 1996; 43(11):1225-9. PubMed ID: 8908555 [TBL] [Abstract][Full Text] [Related]
5. Clinical trial of tamoxifen in patients with irresectable pancreatic adenocarcinoma. The Yorkshire Gastrointestinal Tumour Group. Taylor OM; Benson EA; McMahon MJ Br J Surg; 1993 Mar; 80(3):384-6. PubMed ID: 8472160 [TBL] [Abstract][Full Text] [Related]
6. Tamoxifen therapy in unresectable adenocarcinoma of the pancreas and the papilla of Vater. Bakkevold KE; Pettersen A; Arnesjø B; Espehaug B Br J Surg; 1990 Jul; 77(7):725-30. PubMed ID: 2200555 [TBL] [Abstract][Full Text] [Related]
7. Adenocarcinoma of the pancreas--a hormone sensitive tumor? A preliminary report on Nolvadex treatment. Theve NO; Pousette A; Carlström K Clin Oncol; 1983 Sep; 9(3):193-7. PubMed ID: 6616993 [TBL] [Abstract][Full Text] [Related]
8. Clinico-pathology and prognosis of endometrial cancer in patients previously treated for breast cancer, with or without tamoxifen: a comparative study in 363 patients. Ngô C; Brugier C; Plancher C; de la Rochefordière A; Alran S; Féron JG; Malhaire C; Scholl S; Sastre X; Rouzier R; Fourchotte V; Eur J Surg Oncol; 2014 Oct; 40(10):1237-44. PubMed ID: 25086993 [TBL] [Abstract][Full Text] [Related]
9. Prognosis of malignant intraductal papillary mucinous tumours of the pancreas after surgical resection. Comparison with pancreatic ductal adenocarcinoma. Maire F; Hammel P; Terris B; Paye F; Scoazec JY; Cellier C; Barthet M; O'Toole D; Rufat P; Partensky C; Cuillerier E; Lévy P; Belghiti J; Ruszniewski P Gut; 2002 Nov; 51(5):717-22. PubMed ID: 12377813 [TBL] [Abstract][Full Text] [Related]
10. A prospective randomised controlled trial of tamoxifen and cyproterone acetate in pancreatic carcinoma. Keating JJ; Johnson PJ; Cochrane AM; Gazzard BG; Krasner N; Smith PM; Trewby PN; Wheeler P; Wilkinson SP; Williams R Br J Cancer; 1989 Nov; 60(5):789-92. PubMed ID: 2529892 [TBL] [Abstract][Full Text] [Related]
11. [Tamoxifen for metastatic pancreatic adenocarcinoma: a complete response]. Lamy R; Conroy T; Brunaud L; Bresler L Gastroenterol Clin Biol; 2001 Oct; 25(10):912-3. PubMed ID: 11852397 [TBL] [Abstract][Full Text] [Related]
12. A phase II study to evaluate tamoxifen in pancreatic adenocarcinoma. Crowson MC; Dorrell A; Rolfe EB; Fielding JW Eur J Surg Oncol; 1986 Dec; 12(4):335-6. PubMed ID: 3780986 [TBL] [Abstract][Full Text] [Related]
13. Cross-classification and survival characteristics of 5,000 cases of cancer of the pancreas. Baylor SM; Berg JW J Surg Oncol; 1973; 5(4):335-58. PubMed ID: 4355621 [No Abstract] [Full Text] [Related]
14. [Hormone therapy of postoperative recurrent pancreatic carcinoma with octreotide and tamoxifen]. Wenger FA; Zieren HU; Jacobi CA; Müller JM Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():1348-50. PubMed ID: 9931878 [TBL] [Abstract][Full Text] [Related]
15. Surgical treatment for ductal adenocarcinoma of the pancreas. Condie JD; Nagpal S; Peebles SA Surg Gynecol Obstet; 1989 May; 168(5):437-45. PubMed ID: 2469131 [TBL] [Abstract][Full Text] [Related]
16. Pancreatic ductal adenocarcinoma: is there a survival difference for R1 resections versus locally advanced unresectable tumors? What is a "true" R0 resection? Konstantinidis IT; Warshaw AL; Allen JN; Blaszkowsky LS; Castillo CF; Deshpande V; Hong TS; Kwak EL; Lauwers GY; Ryan DP; Wargo JA; Lillemoe KD; Ferrone CR Ann Surg; 2013 Apr; 257(4):731-6. PubMed ID: 22968073 [TBL] [Abstract][Full Text] [Related]
17. [Analysis of prognosis-associated factors in pancreatic head and peri-ampullary cancer]. Roder JD; Siewert JR Chirurg; 1992 May; 63(5):410-5. PubMed ID: 1376655 [TBL] [Abstract][Full Text] [Related]
19. Pancreatic ductal adenocarcinoma: diagnosis and staging with dynamic CT. Freeny PC; Marks WM; Ryan JA; Traverso LW Radiology; 1988 Jan; 166(1 Pt 1):125-33. PubMed ID: 2827228 [TBL] [Abstract][Full Text] [Related]
20. Tamoxifen therapy improves overall survival in luminal A subtype of ductal carcinoma in situ: a study based on nationwide Korean Breast Cancer Registry database. Hwang KT; Kim EK; Jung SH; Lee ES; Kim SI; Lee S; Park HK; Kim J; Oh S; Kim YA; Breast Cancer Res Treat; 2018 Jun; 169(2):311-322. PubMed ID: 29383628 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]